INTRODUCTION
Plasma gelsolin (pGSN) represents one of the three currently described isoforms of gelsolin [26, 28] . This PIP2-and calcium-regulated protein circulates in blood plasma at a concentration of ~250 µg · ml -1 and is primarily involved in the rapid severing and removal of actin filaments released into the bloodstream from dead and injured cells [17] . This function prevents several toxic effects of circulating F-actin, which activates platelets, slows down fibrinolysis by binding to plasmin [3, 17] , increases blood viscosity [11] , and compromises the viability of endothelial cells [9] . Additionally, direct interaction of gelsolin with bioactive lipids such as lipopolysaccharide [1] , lipoteichoic acid [2, 4] , lysophosphatidic acid [19] , platelet-activating factor [23] and sphingosine 1-phosphate [6] reduces the ability of these molecules to induce cell activation and gelsolin's ability to sever F-actin. All gelsolin isoforms are encoded by a single gene located on chromosome 9 in humans [15] . Skeletal, cardiac, and smooth muscles have large amounts of pGSN mRNA, account for a large fraction of body mass and total protein synthesis, and they are the major source of plasma gelsolin [15] . So far, the factors that regulate pGSN expression in muscles and pGSN concentration in
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runners (average experience of 1.7-4.3 years, between 7 and 10 h per week). For each participant body composition was determined after overnight fasting using an Akern BIA-101 analyzer (Florence, Italy). The study was approved by the Ethical Committee for Human Studies of the Józef Piłsudski University of Physical Education.
All subjects gave their informed consent prior to their inclusion in the study.
Exercise protocol
The study was conducted on two separate days over a 1-week period. In the first step (day one), peak oxygen uptake ( · VO 2 max) was determined using a graded exercise test on a cycloergometer (Ergomedic 839E, Monark Exercise AB, Vansbro, Sweden) starting at 1 W · kg -1 of body weight for 3 min followed by increments of 0.75 W · kg -1 every 3 min until exhaustion. Oxygen consumption was monitored using an online system (Start 2000, MES, Cracow, Poland).
In the second step (six or seven days later), the subjects performed either 30 (UT group) or 60 (ET group) minutes of exercise on the same cycloergometer at a workload estimated to elicit a load of 70% of · VO 2 max. The period of exercise was chosen considering the differences in tolerance to exercise between the UT and ET groups (in a pilot study we observed that only 10% of UT subjects can complete the same 60 min of exercise to which the ET group was subjected in our experimental setting). Subjects were instructed to abstain from alcohol use during the 2 days preceding each visit to the laboratory. Both exercise bouts were performed in the morning, 1 h after a light carbohydrate-rich breakfast.
Blood collection
Blood samples were drawn through a catheter inserted into an antecubital vein into 4.3 ml plastic tubes containing 0.43 ml of 0.106 M sodium citrate solution as an anticoagulant (Sarstedt, Nümbrecht, Germany). Samples were taken just before exercise, after 30 and 60 (ET group only) minutes of pedaling, and after a 30-min rest.
The catheter was kept patent by flushing it regularly with isotonic NaCl solution. Immediately after sampling, blood was centrifuged at 300 g for 10 min at room temperature and plasma was transferred to a fresh plastic tube. Supernatant was then transferred to a fresh plastic tube and re-centrifuged at 5000 g for 10 min to obtain platelet-free plasma. All samples were stored at -80°C until analysis.
Plasma protein concentration was measured using the BCA protein assay kit (Sigma). Bovine serum albumin (fatty acid free, Sigma) was used as a standard. Three volunteers from the ET group were unable to complete the exercise protocol.
Quantitative immunoblotting
Plasma samples were boiled in the presence of sample buffer for 10 min and subjected to electrophoresis on 10% sodium dodecyl sulfate as a standard curve to determine unknown gelsolin levels in simultaneously assayed samples from UT and ET subjects [21] .
Statistical analysis
Data are reported as mean ± SD. Data analysis was performed using two-way analysis of variance (ANOVA) with appropriate post hoc test.
RESULTS
The average age of subjects (all male) included in the study for UT (n=10) and ET (n=10) groups was 20.4±0.7 and 21.1±0.9
years, and lean body mass was 64.6±7.6 and 58.4±2.9 kg respectively. Body mass index (kg · m Change in blood gelsolin concentration in response to physical exercise ercise training in human skeletal muscle have not been fully defined and several mediators, such as catecholamines, adrenocorticotrophic hormone, growth hormone, and proteins associated with skeletal muscle adaptation to the stress of contractile activity such as heat shock proteins (HSPs), have been proposed to govern this process [20, 24] . Since muscle tissue devotes ~3% of its metabolic power to synthesis of extracellular gelsolin [14] it is plausible that increasing gelsolin production occurs in response to exercise. We found that training prevents a decrease of blood gelsolin associated with intense exercise, indicating that an increase of pGSN expression might occur as part of adaptive changes to exercise in skeletal muscle. However, a recent study in which alterations in protein abundance in skeletal muscle after one bout of exhaustive exercise using proteomic analysis was performed did not show any alteration in gelsolin expression [10] . Such an increase might not be easy to capture based on evaluation of blood gelsolin concentration if the increasing production is masked due to increasing demand by the extracellular actin buffering system. In a recent study, a decreased concentration of vitamin D binding protein which also contributes to the blood actin buffering system was observed after a one-hour exercise bout to exhaustion in obese subject [22] . However, no changes in blood gelsolin concentration were observed in those subjects. An observed decrease of blood
FIG. 1. GELSOLIN CONCENTRATION IN PLASMA SAMPLES COLLECTED FROM UNTRAINED (PANELS A AND C) AND ENDURANCE TRAINED (PANELS B AND D) VOLUNTEERS. FROM ALL STUDY PARTICIPANTS, BLOOD SAMPLES WERE TAKEN BEFORE EXERCISE (TIME 0'), AT 30 MINUTES OF EXERCISE (30' -EX) AND 30 MINUTES AFTER COMPLETION OF EXERCISE (30' POST EX). ADDITIONALLY, IN THE ET GROUP BLOOD WAS ALSO COLLECTED AT 60 MINUTES OF EXERCISE (60' -EX). PANEL A AND B SHOW CHANGES OF BLOOD GSN CONCENTRATION IN INDIVIDUAL SUBJECTS BETWEEN TIME 0' AND 30 MINUTES OF EXERCISE IN UT AND ET GROUPS RESPECTIVELY. BOX PLOTS ON PANELS C AND D DISPLAY DIFFERENCES IN BLOOD GELSOLIN CONCENTRATION AT INDICATED TIME POINTS IN UT AND ET GROUPS RESPECTIVELY. THE HORIZONTAL LINE IN THE BOX INDICATES THE MEDIAN. PANEL E SHOWS A REPRESENTATIVE IMAGE OF WESTERN BLOT ANALYSIS OF 4 PLASMA SAMPLES TAKEN FROM 1 SUBJECT OF THE ET GROUP.
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gelsolin concentration in untrained subjects indicates that endurance training might increase the ability of muscle tissue to express plasma gelsolin, which might potentially compensate increasing demand for gelsolin by the extracellular actin buffering system. Administration of recombinant human plasma gelsolin was proposed as a treatment for different conditions in which hypogelsolinemia was observed [8] .
A better understanding of factors that regulate gelsolin production might provide an alternative therapy in which stimulation of endogenous plasma gelsolin by muscle tissue might be used to maintain a healthy gelsolin concentration. A study of blood gelsolin changes during exercise correlated with hormonal and metabolic screening might provide a better strategy to recognize these factors.
CONCLUSIONS
It is concluded that training prevents a decrease of blood gelsolin associated with intense exercise. This may indicate that an increase of pGSN expression might occur as part of adaptive changes to exercise in skeletal muscle.
